Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 28 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 14 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 20 |
NetGPI | no | yes: 0, no: 20 |
Related structures:
AlphaFold database: E9B5X7
Term | Name | Level | Count |
---|---|---|---|
GO:0005975 | carbohydrate metabolic process | 3 | 21 |
GO:0008152 | metabolic process | 1 | 21 |
GO:0044238 | primary metabolic process | 2 | 21 |
GO:0071704 | organic substance metabolic process | 2 | 21 |
GO:0005996 | monosaccharide metabolic process | 3 | 6 |
GO:0019318 | hexose metabolic process | 4 | 6 |
GO:0044281 | small molecule metabolic process | 2 | 6 |
GO:0006006 | glucose metabolic process | 5 | 3 |
GO:0006012 | galactose metabolic process | 5 | 3 |
GO:0009056 | catabolic process | 2 | 3 |
GO:0016052 | carbohydrate catabolic process | 4 | 3 |
GO:0019320 | hexose catabolic process | 5 | 3 |
GO:0019388 | galactose catabolic process | 6 | 3 |
GO:0033499 | galactose catabolic process via UDP-galactose | 7 | 3 |
GO:0044282 | small molecule catabolic process | 3 | 3 |
GO:0046365 | monosaccharide catabolic process | 4 | 3 |
GO:1901575 | organic substance catabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 21 |
GO:0004034 | aldose 1-epimerase activity | 5 | 16 |
GO:0005488 | binding | 1 | 21 |
GO:0016853 | isomerase activity | 2 | 21 |
GO:0016854 | racemase and epimerase activity | 3 | 16 |
GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives | 4 | 16 |
GO:0030246 | carbohydrate binding | 2 | 21 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 353 | 355 | PF00675 | 0.295 |
CLV_PCSK_KEX2_1 | 353 | 355 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 279 | 283 | PF00082 | 0.350 |
DOC_MAPK_gen_1 | 111 | 118 | PF00069 | 0.485 |
DOC_MAPK_gen_1 | 323 | 332 | PF00069 | 0.493 |
DOC_PP1_RVXF_1 | 12 | 18 | PF00149 | 0.481 |
DOC_PP2B_LxvP_1 | 213 | 216 | PF13499 | 0.525 |
DOC_WW_Pin1_4 | 169 | 174 | PF00397 | 0.498 |
DOC_WW_Pin1_4 | 285 | 290 | PF00397 | 0.503 |
LIG_14-3-3_CanoR_1 | 128 | 136 | PF00244 | 0.611 |
LIG_14-3-3_CanoR_1 | 357 | 364 | PF00244 | 0.508 |
LIG_Actin_WH2_2 | 11 | 26 | PF00022 | 0.384 |
LIG_APCC_ABBA_1 | 280 | 285 | PF00400 | 0.501 |
LIG_APCC_ABBAyCdc20_2 | 279 | 285 | PF00400 | 0.501 |
LIG_BIR_III_2 | 175 | 179 | PF00653 | 0.536 |
LIG_Clathr_ClatBox_1 | 15 | 19 | PF01394 | 0.448 |
LIG_eIF4E_1 | 10 | 16 | PF01652 | 0.409 |
LIG_FHA_1 | 119 | 125 | PF00498 | 0.533 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.532 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.558 |
LIG_FHA_1 | 326 | 332 | PF00498 | 0.447 |
LIG_FHA_2 | 160 | 166 | PF00498 | 0.588 |
LIG_FHA_2 | 170 | 176 | PF00498 | 0.572 |
LIG_FHA_2 | 237 | 243 | PF00498 | 0.512 |
LIG_FHA_2 | 361 | 367 | PF00498 | 0.532 |
LIG_FHA_2 | 61 | 67 | PF00498 | 0.559 |
LIG_LIR_Apic_2 | 199 | 205 | PF02991 | 0.556 |
LIG_LIR_Apic_2 | 59 | 65 | PF02991 | 0.505 |
LIG_LIR_Gen_1 | 230 | 241 | PF02991 | 0.619 |
LIG_LIR_Gen_1 | 45 | 55 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 162 | 167 | PF02991 | 0.558 |
LIG_LIR_Nem_3 | 230 | 236 | PF02991 | 0.562 |
LIG_LIR_Nem_3 | 45 | 50 | PF02991 | 0.491 |
LIG_Pex14_2 | 301 | 305 | PF04695 | 0.507 |
LIG_SH2_CRK | 12 | 16 | PF00017 | 0.321 |
LIG_SH2_NCK_1 | 62 | 66 | PF00017 | 0.538 |
LIG_SH2_SRC | 266 | 269 | PF00017 | 0.487 |
LIG_SH2_STAP1 | 12 | 16 | PF00017 | 0.460 |
LIG_SH2_STAP1 | 164 | 168 | PF00017 | 0.550 |
LIG_SH2_STAP1 | 30 | 34 | PF00017 | 0.552 |
LIG_SH2_STAT3 | 91 | 94 | PF00017 | 0.552 |
LIG_SH2_STAT5 | 131 | 134 | PF00017 | 0.533 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 167 | 170 | PF00017 | 0.616 |
LIG_SH2_STAT5 | 307 | 310 | PF00017 | 0.514 |
LIG_SH2_STAT5 | 62 | 65 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 92 | 95 | PF00017 | 0.593 |
LIG_SH3_3 | 342 | 348 | PF00018 | 0.515 |
LIG_SH3_3 | 36 | 42 | PF00018 | 0.560 |
LIG_SH3_3 | 52 | 58 | PF00018 | 0.552 |
LIG_SUMO_SIM_anti_2 | 255 | 260 | PF11976 | 0.583 |
LIG_SUMO_SIM_par_1 | 267 | 273 | PF11976 | 0.526 |
LIG_WRC_WIRS_1 | 147 | 152 | PF05994 | 0.552 |
MOD_CK1_1 | 166 | 172 | PF00069 | 0.593 |
MOD_CK1_1 | 183 | 189 | PF00069 | 0.535 |
MOD_CK1_1 | 288 | 294 | PF00069 | 0.506 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.507 |
MOD_CK1_1 | 360 | 366 | PF00069 | 0.509 |
MOD_CK2_1 | 360 | 366 | PF00069 | 0.520 |
MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.382 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.367 |
MOD_GlcNHglycan | 316 | 319 | PF01048 | 0.319 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.567 |
MOD_GSK3_1 | 159 | 166 | PF00069 | 0.607 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.563 |
MOD_N-GLC_1 | 129 | 134 | PF02516 | 0.347 |
MOD_N-GLC_1 | 335 | 340 | PF02516 | 0.352 |
MOD_N-GLC_2 | 100 | 102 | PF02516 | 0.352 |
MOD_N-GLC_2 | 146 | 148 | PF02516 | 0.352 |
MOD_N-GLC_2 | 292 | 294 | PF02516 | 0.301 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.519 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.532 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.550 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.510 |
MOD_NEK2_2 | 159 | 164 | PF00069 | 0.552 |
MOD_NEK2_2 | 98 | 103 | PF00069 | 0.493 |
MOD_PIKK_1 | 90 | 96 | PF00454 | 0.552 |
MOD_PKA_2 | 325 | 331 | PF00069 | 0.516 |
MOD_Plk_1 | 360 | 366 | PF00069 | 0.521 |
MOD_Plk_2-3 | 232 | 238 | PF00069 | 0.501 |
MOD_Plk_2-3 | 60 | 66 | PF00069 | 0.398 |
MOD_Plk_4 | 159 | 165 | PF00069 | 0.546 |
MOD_ProDKin_1 | 169 | 175 | PF00069 | 0.498 |
MOD_ProDKin_1 | 285 | 291 | PF00069 | 0.503 |
MOD_SUMO_for_1 | 5 | 8 | PF00179 | 0.428 |
TRG_DiLeu_BaEn_1 | 276 | 281 | PF01217 | 0.554 |
TRG_ENDOCYTIC_2 | 12 | 15 | PF00928 | 0.330 |
TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.506 |
TRG_ENDOCYTIC_2 | 298 | 301 | PF00928 | 0.502 |
TRG_ER_diArg_1 | 352 | 354 | PF00400 | 0.550 |
TRG_Pf-PMV_PEXEL_1 | 247 | 251 | PF00026 | 0.316 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0E0RXA9 | Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) | 25% | 85% |
A0A0N0P441 | Leptomonas seymouri | 82% | 100% |
A0A0N0P558 | Leptomonas seymouri | 35% | 91% |
A0A0N1PBB3 | Leptomonas seymouri | 47% | 99% |
A0A1X0NJ33 | Trypanosomatidae | 47% | 98% |
A0A1X0NX70 | Trypanosomatidae | 38% | 97% |
A0A3R7MXQ5 | Trypanosoma rangeli | 36% | 98% |
A0A3S7WXI1 | Leishmania donovani | 33% | 91% |
A0A3S7X8W5 | Leishmania donovani | 94% | 100% |
A0A3S7X8Z3 | Leishmania donovani | 70% | 98% |
A0A422N115 | Trypanosoma rangeli | 44% | 98% |
A4HCQ7 | Leishmania braziliensis | 34% | 100% |
A4I082 | Leishmania infantum | 33% | 91% |
A4IAZ4 | Leishmania infantum | 94% | 100% |
D4AMB9 | Arthroderma benhamiae (strain ATCC MYA-4681 / CBS 112371) | 28% | 84% |
E9AES2 | Leishmania major | 96% | 100% |
E9AES3 | Leishmania major | 70% | 100% |
E9AW46 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
E9B5X8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 69% | 98% |
P05149 | Acinetobacter calcoaceticus | 28% | 97% |
P0A9C3 | Escherichia coli (strain K12) | 29% | 100% |
P0A9C4 | Shigella flexneri | 29% | 100% |
P21955 | Streptococcus thermophilus | 20% | 100% |
P31765 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 28% | 100% |
P38893 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 22% | 100% |
P53757 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 100% |
Q03PA4 | Levilactobacillus brevis (strain ATCC 367 / BCRC 12310 / CIP 105137 / JCM 1170 / LMG 11437 / NCIMB 947 / NCTC 947) | 25% | 100% |
Q4QBD1 | Leishmania major | 35% | 100% |
Q5EA79 | Bos taurus | 27% | 100% |
Q5R8U1 | Pongo abelii | 26% | 100% |
Q66HG4 | Rattus norvegicus | 28% | 100% |
Q8K157 | Mus musculus | 28% | 100% |
Q96C23 | Homo sapiens | 26% | 100% |
Q9GKX6 | Sus scrofa | 27% | 100% |
V5B7Z0 | Trypanosoma cruzi | 36% | 96% |